Clinical Trials Logo

Clinical Trial Summary

This is a prospective, randomized (Reading Center), masked, controlled study in up to 45 subjects who have undergone bilateral PRK with epithelial removal using alcohol in a 9.0 mm well or trephine at the time of surgery to ensure consistency of the size of the ablation area.


Clinical Trial Description

This is a prospective, randomized (Reading Center), masked, controlled study in up to 45 subjects who have undergone bilateral PRK with epithelial removal using alcohol in a 9.0 mm well or trephine at the time of surgery to ensure consistency of the size of the ablation area. Subjects will be assigned to one of three treatment arms on Day 0. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03163641
Study type Interventional
Source Eyegate Pharmaceuticals, Inc.
Contact
Status Completed
Phase N/A
Start date August 5, 2018
Completion date November 8, 2018

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05331859 - Topical Insulin Versus Autologous Serum After Corneal Surgeries Phase 1
Completed NCT01441648 - Influence of Cosmetic Color Tinted Contact Lenses on the Ocular Surface N/A